Asia bioscience grows 11 percent, crosses $150 bn
Industry Insights | Analysis | By Nandita Singh | 0 Comment | 21 Jun, 2013
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...Read more
Dr. Reddy's makes a mark in the US generics market
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Striking profit on a high note, Dr. Reddy's crossed $1.5 billion worth of business in 2012, marking a growth of 22 per...Read more
Aurobindo Pharma revamps strategy to accelerate growth
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Aurobindo Pharma, ranked among the top pharmaceutical company in India, clocked $1 billion revenue in 2012. Aurobindo ...Read more
ResMed builds on partnerships for growth
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 14 Jun, 2012
Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisiti...Read more
Bioscience Industry clocks $139 bn, grows 8.37%
Industry Insights | Analysis | By Nandita Singh | 0 Comment | 03 Jul, 2012
The bioscience industry in the Asia Pacific region, in 2011, got pulled back into a low growth cycle. In a replay of 200...Read more
Sigma Pharma leverages on its pharmacy business
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 31 May, 2013
Marking a strong presence of 100 years in the pharmaceutical sector in the year 2012, Sigma Pharmaceuticals retained i...Read more
Shenzhen Neptunus invests in drug innovation
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Shenzhen Neptunus Bioengineering is a well-recognized name in manufacturing and distribution of pharmaceutical product...Read more
China holds largest pharma revenue share in APAC
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
In 2011, China maintained its top position in the Asia Pacific's region for pharmaceutical industry, with the largest sh...Read more
China secures rank 1 in terms of total company revenues
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
China emerged as the third country in terms of the total revenue generated by companies during the calendar year 2012 in...Read more
China, Australia dominate APAC pharma market
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 201...Read more
China National Accord's R&D strategy begins to pay-off
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 31 May, 2013
China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scienti...Read more
India's 127-year-old ayurvedic leader clocks $847 mn
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013
Growing on its legacy of 127 years, Dabur India clocked $847 million in 2012. The company is recognized for manufactur...Read more
What were Asia's Top 20 bio companies in 2012?
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2013
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...Read more
What were the top 20 global M&A transactions of 2012?
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2013
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing ...Read more
Why did mergers & acquisitions plunge in APAC?
Industry Insights | Analysis | By BioSpectrum Bureau | 1 Comment | 12 Jun, 2013
The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 bill...Read more
Sanjiu Medical keeps focus on R&D
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 21 Jun, 2012
Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medic...Read more
TCM leader Yunnan Baiyao rides on R&D strength
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 03 Jun, 2013
Yunnan Baiyao Group is expanding its forte in the domain of traditional Chinese medicines and is concentrating on stre...Read more
Baraclude tops Korea pharma products list
Industry Insights | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Korea, whose pharma market is being fueled by an aging population with a rising demand for drugs, made it to the top thr...Read more